Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Support

This activity is supported by an educational grant from American Regent.

Clinical Consultations™: Understanding the Need for Proper Recognition and Management of Iron Deficiency Anemia in Patients with IBD

Release Date: November 12, 2020
Expiration Date: November 12, 2021

Activity Overview

This online educational activity is designed to provide expert interpretation of current and emerging data on the diagnosis and treatment of iron deficiency anemia (IDA) in patients with inflammatory bowel disease (IBD). New guideline recommendations, diagnostic considerations, and therapeutic options are presented in a series of videos featuring 2 expert physicians conversing about the nuances of IDA/IBD and various clinical scenarios.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from American Regent. 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This online educational activity is directed towards gastroenterologists, primary care providers, obstetricians/gynecologists, hematologists, physicians, nurse practitioners, physician assistants, and nurses. Additional health care clinicians involved in the management of IDA in patients with IBD will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Discuss the pathophysiology, etiology, and burden of IDA in patients with concomitant IBD
  • Review screening criteria, diagnosis, and therapeutic interventions for optimal management of IDA in patients with concomitant IBD
  • Analyze current data regarding efficacy, safety, administration routes, and clinical suitability to select individualized treatment strategies for optimal management of IDA in patients with concomitant IBD

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Gary R. Lichtenstein, MD
Gary R. Lichtenstein, MD
Professor of Medicine
Director, Center for Inflammatory Bowel Diseases
The Raymond and Ruth Perelman School of Medicine of the University of Pennsylvania
Hospital of the University of Pennsylvania
Gastroenterology Division, Department of Internal Medicine
Perelman Center for Advanced Medicine
Philadelphia, PA

Disclosures: Grant/Research Support: Celgene, Janssen Orthobiotech, Pfizer Pharmaceuticals, Takeda. Consultant: Abbvie, CellCeutrix, Celgene, Endo Pharmaceuticals, Ferring, Gilead, Janssen Orthobiotech, Eli Lilly, Merck, Morphic Therapeutics, Pfizer Pharmaceuticals, Prometheus Laboratories, Inc., Romark, Salix Pharmaceuticals / Valeant, Shire Pharmaceuticals, Takeda, UCB.

Stephen B. Hanauer, MD
Stephen B. Hanauer, MD
Professor of Medicine
Medical Director of Digestive Health Center
Chicago, IL

Disclosures: Consultant: AbbVie, Allergan, Amgen, Arena,Boehringer lngelheim, Bristol Myers Squibb, Celgene, Celtrion, Genentech, Gilead, GSK, Janssen, Lilly,, Merck, Nestle, Novartis, Pfizer, Progenity, Prometheus, Receptos, Salix, Samsung Bioepis, SeresTherapeutics, Takeda, Tigencx, UCB Pharma, VHsquared. Speaker's Bureau: AbbVie, Janssen, Pfizer, Takeda, American Regent.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By